LSD和psilocybin对大脑血流产生相反影响,研究显示
LSD and psilocybin push brain blood flow in opposite directions, study suggests
研究人员使用PET和MRI技术研究了LSD对健康志愿者大脑血流的影响,发现LSD增加血流并减少功能性连接,而psilocybin则相反。研究有助于理解这些药物的作用机制。
研究揭示了LSD和psilocybin对大脑血流的不同影响,有助于理解这些药物的潜在机制。
Psychedelics are a class of compounds that alter people's perceptions, mood and mental processes. Recent clinical studies suggest that some of these compounds, such as lysergic acid diethylamide (LSD) and psilocybin, could be promising for the treatment of depression and other psychiatric disorders.
Despite these encouraging results, the molecular and neural processes via which they could improve psychiatric symptoms remain poorly understood. Delineating these processes could inform future clinical studies and potentially help to devise more effective psychedelic treatments.
Researchers at Rigshospitalet, the University of Copenhagen and other institutions recently combined different imaging techniques to investigate the effects of LSD on the brains of healthy volunteers, comparing their findings with data collected as part of an earlier study with psilocybin. The results of their analyses, published in Nature Neuroscience, suggest that the two drugs have different effects on cerebral blood flow, while also offering insight into how LSD binds to serotonin 2A receptors in the brain.
"We wanted to better understand how LSD affects the human brain, from its molecular interactions to its effects on brain activity and subjective experience," Gitte Moos Knudsen, co-senior author of the paper, told Medical Xpress.
"Although psychedelics are receiving increasing attention for their potential therapeutic applications, the exact mode of action underlying their effects remains incompletely understood. Our main objective was to combine molecular imaging with measurements of brain physiology to investigate how LSD engages the brain's serotonin 2A receptors and how this relates to changes in cerebral blood flow, functional brain connectivity and subjective effects."
LSD-related serotonin receptor occupancy and cerebral blood flow
Moos Knudsen and her colleagues gave varying doses of LSD to 11 healthy volunteers, all of whom completed baseline brain scans before taking the drug. They also collected usable brain scans from seven participants while the drug's effects were at their peak.
The brain scans were captured using two different techniques called positron emission tomography (PET) and magnetic resonance imaging (MRI). PET is an imaging technique that relies on a radioactive tracer to measure biological processes, such as the availability of specific receptors in the brain.
MRI, on the other hand, uses strong magnetic fields and radio waves to produce detailed images of the brain or other parts of the body. Some types of MRI can also be used to measure blood flow.
"PET imaging allowed us to measure occupancy of serotonin 2A receptors, while MRI was used to assess cerebral blood flow and functional connectivity between brain regions," explained Moos Knudsen. "We also measured LSD concentrations in participants' blood and assessed their subjective experiences. This integrated approach allowed us to investigate relationships between the drug's concentration, receptor engagement and changes in brain function."
The researchers also analyzed data from an earlier experiment with 25 participants who had received the psychedelic compound psilocybin. This allowed them to compare the effects of LSD on cerebral blood flow to those of psilocybin.
The researchers found that LSD bound strongly to serotonin 2A receptors, increased blood flow to the brain and decreased global functional connectivity. Participants who had taken psilocybin, on the other hand, exhibited an opposite pattern of decreased cerebral blood flow and increased global functional connectivity.
"Changes in blood flow and connectivity were negatively associated, as was the case for psilocybin, suggesting that these measurements capture complementary aspects of the brain's response to the drug," said Moos Knudsen. "We also observed a counterclockwise hysteresis pattern between LSD concentrations in the blood and subjective effects, indicating that the relationship between drug concentration and experience changes over time."
Guiding future imaging and clinical studies with psychedelics
This recent study highlights the potential of combining molecular and physiological imaging techniques to explore the effects of psychedelics on the brain. The team's findings could inform further research focusing on how LSD and psilocybin affect cerebral blood flow and what receptors they bind to.
The researchers did not establish whether the psychedelic-related changes they observed could be responsible for the therapeutic benefits of the two drugs. In their next studies, they will try to determine whether LSD alters the connection between brain activity and cerebral blood flow, which is known as neurovascular coupling.
"This could explain some previously published results with psychedelic drugs," added Moos Knudsen. "Moreover, measurements of brain neuroplasticity in the temporal course after a psychedelic drug could help establish if there is a window of neuroplasticity that could be utilized for augmentation strategies, either through brain stimulation or psychotherapy. Research in this area may establish whether particular brain mechanisms are associated with therapeutic effects of psychedelics and potentially also help develop novel drugs."
Written for you by our author Ingrid Fadelli, edited by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You'll get an ad-free account as a thank-you.
Publication details
Drummond E-Wen McCulloch et al., Investigating molecular and hemodynamic effects of LSD in the human brain, Nature Neuroscience (2026). DOI: 10.1038/s41593-026-02462-2. On medRxiv: www.medrxiv.org/content/10.110 … 6.17.25329677v2.full
Journal information: Nature Neuroscience , medRxiv
Who's behind this story?
Ingrid Fadelli
Freelance journalist with BSc Psychology and MA International Journalism. Covers AI, robotics, neuroscience, and astrophysics since 2018. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
© 2026 Science X Network
Citation: LSD and psilocybin push brain blood flow in opposite directions, study suggests (2026, October 28) retrieved 28 October 2026 from https://medicalxpress.com/news/2026-10-lsd-psilocybin-brain-blood.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com